FDA Inspection 1062455 — American Red Cross Biomedical Services

American Red Cross Biomedical Services — FEI 1000117740

The FDA completed an inspection of American Red Cross Biomedical Services on July 18, 2018 in Mountain Home, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 18, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mountain Home, AR (United States)